CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-23 | Lewis William Chair and CEO | Sale 10b5-1 | −5,872 | $106.43 | $625K | 259,058 |
| 2026-07-23 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,260 | 0 | ||
| 2026-07-23 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 0 | ||
| 2026-07-09 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 265,317 |
| 2026-07-09 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 269,757 |
| 2026-07-09 | Lewis William Chair and CEO | Sale 10b5-1 | −5,005 | $116.55 | $583K | 264,752 |
| 2026-07-09 | Lewis William Chair and CEO | Sale 10b5-1 | −2,335 | $117.62 | $275K | 262,417 |
| 2026-07-09 | Lewis William Chair and CEO | Sale 10b5-1 | −3,359 | $118.52 | $398K | 259,058 |
| 2026-07-09 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 6,260 | ||
| 2026-07-09 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 4,440 | ||
| 2026-07-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +7,945 | $29.13 | $231K | 68,431 |
| 2026-07-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +4,357 | $19.74 | $86K | 72,788 |
| 2026-07-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −4,854 | $109.02 | $529K | 67,934 |
| 2026-07-06 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −7,448 | $110.60 | $824K | 60,486 |
| 2026-07-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −7,945 | 23,835 | ||
| 2026-07-06 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −4,357 | 4,358 | ||
| 2026-06-25 | Lewis William Chair and CEO | Option exercise 10b5-1 | +12,518 | $30.46 | $381K | 271,435 |
| 2026-06-25 | Lewis William Chair and CEO | Option exercise 10b5-1 | +8,880 | $17.16 | $152K | 280,315 |
| 2026-06-25 | Lewis William Chair and CEO | Sale 10b5-1 | −12,091 | $102.34 | $1.2M | 268,224 |
| 2026-06-25 | Lewis William Chair and CEO | Sale 10b5-1 | −1,836 | $103.10 | $189K | 266,388 |
Page 2 of 23 · 448 trades